ZYRTEC
What it isSecond-generation H1 antagonist; allergic rhinitis and urticaria.
Why it mattersAmong OTC second-generation agents, it is especially effective for urticaria but more likely to cause drowsiness.
What it changesReduce in renal impairment and warn about driving until sedation is known; alcohol and other sedatives add impairment.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Allergy symptoms | Adult & children >=6 yr | 10 mg QD | 10 mg QD (5 mg may suffice for milder symptoms) | 10 mg/24h |
Renal Undefined
Hepatic Undefined
Pregnancy Undefined
Lactation Undefined
NO BOXED WARNINGS
Principal riskSedation, more than loratadine
Cost, est. cash$10–$400/month
Generic entry2007
Legacy pregnancy categoryB
Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.

Open Cetirizine in the interactive console ↗

